These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 6315150)

  • 1. The effects of cholecystokinin on dopaminergic mechanisms in rat striatum.
    Mashal RD; Owen F; Deakin JF; Poulter M
    Brain Res; 1983 Oct; 277(2):375-6. PubMed ID: 6315150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aging brain and dopamine receptors: abnormal regulation by CCK-8 of 3H-spiperone labeled dopamine receptors in striatal membranes.
    Agnati LF; Fuxe K; Battistini N; Benfenati F
    Acta Physiol Scand; 1984 Mar; 120(3):465-7. PubMed ID: 6331074
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of cholecystokinin octapeptide on rat striatal 3H spiperone binding.
    O'Shaughnessy C; Poat JA; Turnbull MJ
    Biochem Pharmacol; 1985 Aug; 34(15):2675-7. PubMed ID: 4015708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of acute and chronic treatments with clozapine and haloperidol on serotonin (5-HT2) and dopamine (D2) receptors in the rat brain.
    Wilmot CA; Szczepanik AM
    Brain Res; 1989 May; 487(2):288-98. PubMed ID: 2525063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential modulation by CCK-8 and CCK-4 of [3H]spiperone binding sites linked to dopamine and 5-hydroxytryptamine receptors in the brain of the rat.
    Agnati LF; Fuxe K; Benfenati F; Celani MF; Battistini N; Mutt V; Cavicchioli L; Galli G; Hökfelt T
    Neurosci Lett; 1983 Feb; 35(2):179-83. PubMed ID: 6304577
    [No Abstract]   [Full Text] [Related]  

  • 6. Time-related changes in serum perphenazine, striatal 3H-spiperone binding and regional brain acid metabolites of dopamine and 5-hydroxy-tryptamine after a single dose of perphenazine.
    Mjörndal T; Persson SA
    Fundam Clin Pharmacol; 1990; 4(2):213-22. PubMed ID: 1693589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholecystokinin peptides in vitro modulate the characteristics of the striatal 3H-N-propylnorapomorphine sites.
    Agnati LF; Celani MF; Fuxe K
    Acta Physiol Scand; 1983 May; 118(1):79-81. PubMed ID: 6312748
    [No Abstract]   [Full Text] [Related]  

  • 8. Regional changes of striatal dopamine receptors following denervation by 6-hydroxydopamine and fetal mesencephalic grafts in the rat.
    Gagnon C; Bédard PJ; Rioux L; Gaudin D; Martinoli MG; Pelletier G; Di Paolo T
    Brain Res; 1991 Sep; 558(2):251-63. PubMed ID: 1838295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endurance training effects on striatal D2 dopamine receptor binding and striatal dopamine metabolite levels.
    MacRae PG; Spirduso WW; Cartee GD; Farrar RP; Wilcox RE
    Neurosci Lett; 1987 Aug; 79(1-2):138-44. PubMed ID: 2959886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of subacute treatment with toluene on central monoamine receptors in the rat. Reduced affinity in [3H]5-hydroxytryptamine binding sites and in [3H]spiperone binding sites linked to dopamine receptors.
    Celani MF; Fuxe K; Agnati LF; Andersson K; Hansson T; Gustafsson JA; Battistini N; Eneroth P
    Toxicol Lett; 1983 Jul; 17(3-4):275-81. PubMed ID: 6623522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine receptor elevation by cholecystokinin.
    Dumbrille-Ross A; Seeman P
    Peptides; 1984; 5(6):1207-12. PubMed ID: 6531273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential modulation of dopamine D2 receptors by chronic haloperidol, nitrendipine, and pimozide.
    Tecott LH; Kwong LL; Uhr S; Peroutka SJ
    Biol Psychiatry; 1986 Oct; 21(12):1114-22. PubMed ID: 2428411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of a fluorinated pyrimidinedione anti-cancer drug, 5-fluoro-1-(tetrahydro-2-furanyl)-2,4-pyrimidinedione (FT), and related compounds on nigro-striatal dopaminergic neurons in the central nervous system.
    Toide K; Unemi N; Segawa T
    Arch Int Pharmacodyn Ther; 1985 Mar; 274(1):111-24. PubMed ID: 3925907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraventricular infusion of leupeptin decreases Bmax of the D2 receptor in the striatum of young rats.
    Shibata M; Kanai S; Ivy GO; Ohta M; Asakura M; Aoba A; Hasegawa K; Kitani K
    Life Sci; 1992; 50(19):1451-7. PubMed ID: 1533437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinctions between ligand-binding sites for [3H]dopamine and D2 dopaminergic receptors characterized with [3H]spiroperidol.
    Hancock AA; Marsh CL
    Mol Pharmacol; 1984 Nov; 26(3):439-51. PubMed ID: 6238230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholecystokinin-dopamine receptor interactions as studied with cholecystokinin receptor antagonists.
    Murphy RB
    Prog Clin Biol Res; 1985; 192():105-13. PubMed ID: 3001746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of striatal dopamine release by the selective D-2 dopamine receptor agonist N-0437 is blocked by quinine.
    Cass WA; Zahniser NR
    Synapse; 1990; 5(4):336-7. PubMed ID: 2141733
    [No Abstract]   [Full Text] [Related]  

  • 18. Cerebral decortication reverses the effect of amphetamine on striatal D2 dopamine binding site density.
    Robertson HA
    Neurosci Lett; 1986 Dec; 72(3):325-9. PubMed ID: 2950342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine D2 receptors in the striatum and frontal cortex following chronic administration of haloperidol.
    Liskowsky DR; Potter LT
    Neuropharmacology; 1987 May; 26(5):481-3. PubMed ID: 2955242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lasting changes in high affinity 3H-spiperone binding to the rat striatum and mesolimbic area after chronic methamphetamine administration: evaluation of dopaminergic and serotonergic receptor components.
    Akiyama K; Sato M; Kashihara K; Otsuki S
    Biol Psychiatry; 1982 Dec; 17(12):1389-402. PubMed ID: 7159638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.